Cardiovascular Diseases and Depression: Treatment and Prevention in Psychocardiology

526 Pages·2016·5.763 MB·English

by  Bernhard T. Baune, Phillip J. Tully (eds.)

Cardiovascular
Diseases and
Depression
Treatment and Prevention
in Psychocardiology
Bernhard T. Baune
Phillip J. Tully
Editors
123
Cardiovascular Diseases and Depression

Bernhard T . Baune • Phillip J. Tully
Editors
Cardiovascular Diseases
and Depression
Treatment and Prevention
in Psychocardiology
Editors
Bernhard T. Baune Phillip J. Tully
Discipline of Psychiatry, The Freemason’s Foundation Centre for
School of Medicine Men’s Health, Discipline of Medicine,
University of Adelaide School of Medicine,
Adelaide University of Adelaide
Australia Adelaide, SA
Australia
ISBN 978-3-319-32478-4 ISBN 978-3-319-32480-7 (eBook)
DOI 10.1007/978-3-319-32480-7
Library of Congress Control Number: 2016947729
© Springer International Publishing Switzerland 2016
T his work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of
the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation,
broadcasting, reproduction on microfi lms or in any other physical way, and transmission or information
storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology
now known or hereafter developed.
T he use of general descriptive names, registered names, trademarks, service marks, etc. in this publication
does not imply, even in the absence of a specifi c statement, that such names are exempt from the relevant
protective laws and regulations and therefore free for general use.
T he publisher, the authors and the editors are safe to assume that the advice and information in this book
are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the
editors give a warranty, express or implied, with respect to the material contained herein or for any errors
or omissions that may have been made.
Printed on acid-free paper
This Springer imprint is published by Springer Nature
The registered company is Springer International Publishing AG Switzerland
Contents
1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Bernhard T. Baune and Phillip J. Tully
2 Epidemiology of Cardiovascular Disease and Depression . . . . . . . . . . . 5
Tracy Air , Phillip J. Tully , Shaun Sweeney , and John Beltrame
3 The Risk Relationship Between Depression
and CVD During Ageing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Simone Reppermund and Ruby S. M. Tsang
4 Mechanisms Linking Depression to Cardiovascular Disease:
What Do Epidemiological Studies Tell Us? . . . . . . . . . . . . . . . . . . . . . . 37
Brenda W. J. H. Penninx
5 Anxiety and the Effects on Cardiovascular Disease . . . . . . . . . . . . . . . 53
Phillip J. Tully and Bernhard T. Baune
6 A Clinical Cardiology Perspective of Psychocardiology . . . . . . . . . . . . 71
John F. Beltrame and Rosanna Tavella
7 The Validity of Vascular Depression as a Diagnostic Construct . . . . . . 81
Lauren Taylor , Adith Mohan , and Perminder S. Sachdev
8 Mental Stress-Induced Myocardial Ischemia . . . . . . . . . . . . . . . . . . . . 105
Viola Vaccarino
9 Neuropsychological Impairment of Patients with Depression . . . . . . 123
Thomas Beblo
10 Neuroimaging of Risk Factors of Depression
and Cardiovascular Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
Nils Opel , Udo Dannlowski , and Ronny Redlich
11 Heart Rate Variability, Affective Disorders and Health . . . . . . . . . . . 167
A. H. Kemp
12 Arterial Stiffness in the Depression and Cardiovascular
Comorbidity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187
Evelyn Smith and Joel Singer
v
vi Contents
13 Depression and Markers of Arteriosclerosis: Cross-Sectional
Analyses of the Baseline Examination of the BiDirect
Cohort Study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195
Maren Nagel and Hans-Werner Hense
14 Metabolic-Inflammation Aspects of Depression
and Cardiovascular Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 211
Joshua D. Rosenblat , Ron Kakar , and Roger S. McIntyre
15 Genetic Overlap Between Depression and Cardiometabolic
Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235
Azmeraw T. Amare , Klaus Oliver Schubert , and Bernhard T. Baune
16 Emotional Word Processing in Cardiovascular Disease,
Depression, and Depression Subtypes . . . . . . . . . . . . . . . . . . . . . . . . . . 257
Henning Teismann , Britta Radenz, Johanna Kissler ,
and Klaus Berger
17 Nutrition and Depression: Current Evidence on the Association
of Dietary Patterns with Depression and Its Subtypes . . . . . . . . . . . . 279
Corinna Rahe and Klaus Berger
18 Cardiometabolic Risk and Monitoring in Psychiatric Disorders . . . . 305
Katherine Samaras
19 Monitoring for Metabolic Dysfunction and Cardiovascular
Disease in Bipolar Disorder: A Shared Illness
Process Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 333
Tim Outhred , Claire McAulay , Danielle Gessler , and Gin S. Malhi
20 Assessment and Psychological Interventions for Depression
Comorbid with Cardiovascular Disease . . . . . . . . . . . . . . . . . . . . . . . . 351
Evelyn Smith and Ian Kneebone
21 Moving Beyond Mood: Is it Time to Recommend Cognitive
Training for Depression in Older Adults? . . . . . . . . . . . . . . . . . . . . . . 365
Sharon L. Naismith and Loren Mowszowski
22 The Internet and Mobile Technology: A Platform for Behavior
Change and Intervention in Depression and CVDs . . . . . . . . . . . . . . . 395
Harald Baumeister , Yannik Terhorst , and Jiaxi Lin
23 Pharmacological Treatment and Prevention of Cardiovascular
Diseases and Depression Comorbidity: Understanding
Epidemiological, Clinical Trial Evidence, and the Biological
Underpinnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 411
Harris A. Eyre , Malcolm Forbes , Helen Lavretsky ,
and Bernhard T. Baune
Contents vii
24 Anti-inflammatory Agents for the Treatment of Depression
in the Light of Comorbid Cardiovascular Disease . . . . . . . . . . . . . . . . 445
Ole Köhler and Christiane Gasse
25 The Use of Complementary Alternative and Integrative
Medicine (CAIM) for Treatment and Prevention of Late- Life
Depression and Cardiovascular Disease . . . . . . . . . . . . . . . . . . . . . . . . 467
Taya Varteresian and Helen Lavretsky
26 An Integrative Psychosomatic Approach to the Treatment
of Patients with Cardiovascular Diseases: Concepts
and Experiences of a Dedicated Psychocardiology Ward
at the University of Göttingen Medical Center . . . . . . . . . . . . . . . . . . 493
Marvin Olewinski , Anne-Maria Paschke , Anahit Mohebbi ,
Christoph Herrmann-Lingen , and Christina Kleiber
27 Prevention of CVD in Depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 509
Kate Margaret Scott
28 Screening for Depression in Coronary Heart Disease:
Detection of Early Disease States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 519
Malcolm P. Forbes and Harris A. Eyre
1
Introduction
Bernhard T. Baune and Phillip J. Tully
Content
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
T he association between cardiovascular diseases (CVDs) and depression has long
been recognized. Reports as early as 1937 suggested that institutionalized psychiat-
ric patients had an eight times higher mortality rate than the general population and
“diseases of the heart” accounting for almost 40 % of these deaths (Malzberg 1 937 ).
In the following decades, the comorbidity of depression and CVDs has been
rigorously investigated in many cross-sectional and longitudinal studies pointing to
an important clinical and societal burden. Current literature suggests that the rela-
tionship between CVD and depression is bidirectional. Numerous clinical and epi-
demiological studies investigating the association between depression and
cardiovascular disease have suggested that depression increases the risk of subse-
quent CVD 1.5-fold on average (Grippo and Johnson 2 002; Thombs et al. 2006 ;
Lippi et al. 2009; Nicholson et al. 2006) and that patients with coronary artery dis-
ease and depression have a two- to threefold increased risk of future nonfatal and
fatal cardiac events compared to those cardiac patients without depression (Goldston
and Baillie 2 008 ; Kooy et al. 2 007 ; Rudisch and Charles 2 003 ; Frasure-Smith and
B. T. Baune (*)
Department of Psychiatry, North Terrace , School of Medicine, University of Adelaide ,
Adelaide 5005 , Australia
e-mail: [email protected]
P. J. Tully
School of Medicine, Discipline of Medicine , The University of Adelaide ,
Adelaide 5005 , Australia
© Springer International Publishing Switzerland 2016 1
B.T. Baune, P.J. Tully (eds.), Cardiovascular Diseases and Depression,
DOI 10.1007/978-3-319-32480-7_1
2 B.T. Baune and P.J. Tully
Lesperance 2 010) . Moreover, depression has been found to be an independent pre-
dictor of a poorer health outcome after an ischemic event (Nicholson et al. 2 006 ;
Barth et al. 2 004 ; Meijer et al. 2 011 ).
W hile the etiology and pathophysiology of the relationship between depression
and CVD have been heavily related to various biological mechanisms relating to the
hypothalamic-pituitary-adrenal (HPA) axis, pro-infl ammatory cytokines, increased
sympathetic tone, platelet dysfunction, changes in arterial vessel elasticity, and
endothelial function, other reports support important contributions of clinical char-
acteristics of depression (e.g., severity of depression, number of episodes, duration
of depression, depression subtype) and sociodemographic factors (marital status,
education, and income) to the bidirectional relationship between depression and
cardiovascular disease. Whether screening for and treatment of depression are
effective in reducing the clinical comorbidity and in improving health outcomes in
affected patients, e.g., by using antidepressants, psychotherapy, or anti-
infl ammatories, became of increasing interest in recent years.
I n this most comprehensive book on the topic of cardiovascular disease and
depression, expert authors from around the world focus on novel aspects of the
clinical and biological etiology and pathophysiology of the comorbidity by extend-
ing into new frontiers such as the role of anxiety, neuropsychological and cognitive
impairment, emotion processing, and stress and into the underlying neurobiology of
the cardiovascular disease and depression comorbidity. To extend the more estab-
lished knowledge on biological mechanisms of the cardiovascular and depression
comorbidity as reviewed here, the book will go beyond in order to review neuroim-
aging fi ndings, metabolic-infl ammation aspects, and the possibility of a genetic
overlap between the two conditions. The second main focus of the book is on the
topics of treatment and prevention. State-of-the art psychological (e.g., behavioral
activation, cognitive training, mobile-app technologies) and pharmacological (e.g.,
antidepressants, anti-infl ammatory agents) as well as complementary alternative
and integrative medicine approaches carry promise to improve the short-term and
long-term outcomes of this comorbid condition. Finally, the critical topics of screen-
ing and prevention will be given extensive consideration.
T he broad concept and the comprehensive topics of this book make it a unique
reference for the interested student, clinician, and researcher across medical, psy-
chological, public and allied health, and complementary medicine disciplines to
better understand the foundations and to clinically improve the conditions of people
with cardiovascular and depression comorbidity.
References
B arth J, Schumacher M, Herrmann-Lingen C (2004) Depression as a risk factor for mortality in
patients with coronary heart disease: a meta-analysis. Psychosom Med 66(6):802–813
Frasure-Smith N, Lesperance F (2010) Depression and cardiac risk: present status and future direc-
tions. Heart 96(3):173–176